KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Depreciation and Depletion (2016 - 2025)

Quest Diagnostics' Depreciation and Depletion history spans 17 years, with the latest figure at $103.0 million for Q3 2025.

  • For Q3 2025, Depreciation and Depletion changed N/A year-over-year to $103.0 million; the TTM value through Sep 2025 reached $359.0 million, changed N/A, while the annual FY2021 figure was $305.0 million, 18.22% up from the prior year.
  • Depreciation and Depletion for Q3 2025 was $103.0 million at Quest Diagnostics, up from $88.0 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $103.0 million in Q3 2025 and bottomed at $74.0 million in Q1 2021.
  • The 5-year median for Depreciation and Depletion is $81.0 million (2022), against an average of $83.7 million.
  • The largest annual shift saw Depreciation and Depletion increased 2.53% in 2023 before it increased 7.41% in 2024.
  • A 5-year view of Depreciation and Depletion shows it stood at $80.0 million in 2021, then increased by 1.25% to $81.0 million in 2022, then changed by 0.0% to $81.0 million in 2023, then increased by 8.64% to $88.0 million in 2024, then grew by 17.05% to $103.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Depreciation and Depletion are $103.0 million (Q3 2025), $88.0 million (Q2 2024), and $87.0 million (Q1 2024).